{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:48:37Z","timestamp":1785876517483,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013840","name":"Biocenter Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007417","name":"The Paulo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023879","name":"Rosa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006706","name":"Tampere Tuberculosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008493","name":"V\u00e4in\u00f6 and Laina Kivi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orion Research Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008469","name":"Filha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119037","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:56:30Z","timestamp":1780530990000},"page":"119037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["First-in-class nonsteroidal anti-inflammatory drug and carbonic anhydrase inhibitor hybrid compounds as effective antimycobacterial agents"],"prefix":"10.1016","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8314-041X","authenticated-orcid":false,"given":"Jenny","family":"Parkkinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0011-7888","authenticated-orcid":false,"given":"\u00d6zlem","family":"Akgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-0678","authenticated-orcid":false,"given":"Emanuela","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-6146","authenticated-orcid":false,"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9568-354X","authenticated-orcid":false,"given":"Silvia","family":"Selleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9076-8782","authenticated-orcid":false,"given":"Milka","family":"Hammar\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6938-7835","authenticated-orcid":false,"given":"Ashok","family":"Aspatwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5631-8769","authenticated-orcid":false,"given":"Gianluca","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3314-2411","authenticated-orcid":false,"given":"Clemente","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5555-3815","authenticated-orcid":false,"given":"Mataleena","family":"Parikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7323-8536","authenticated-orcid":false,"given":"Seppo","family":"Parkkila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119037_bib1","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119037_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mSystems.00500-21","article-title":"Surface-shaving proteomics of Mycobacterium marinum identifies biofilm subtype-specific changes affecting virulence, tolerance, and persistence","volume":"6","author":"Savijoki","year":"2021","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119037_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2958.2008.06274.x","article-title":"Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug\u2010tolerant bacteria","volume":"69","author":"Ojha","year":"2008","journal-title":"Mol. Microbiol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119037_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119037_bib5","first-page":"717","article-title":"Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong","volume":"5","author":"Leung","year":"2001","journal-title":"Int. J. Tuberc. Lung Dis"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119037_bib6","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1007\/s00253-021-11361-4","article-title":"Gene expression profile analysis and target gene discovery of Mycobacterium tuberculosis biofilm","volume":"105","author":"Ma","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119037_bib7","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-021-21748-6","article-title":"Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119037_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119037_bib9","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/cid\/civ631","article-title":"Host-Directed Therapies Network (Hdt-Net) Consortium (2015). Host-directed therapies for tackling multi-drug resistant tuberculosis: learning from the pasteur-bechamp debates","volume":"61","author":"Zumla","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119037_bib10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1128\/MMBR.00032-13","article-title":"Host-directed therapeutics for tuberculosis: can we harness the host?","volume":"77","author":"Hawn","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2026.119037_bib11","first-page":"167","article-title":"Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review","volume":"vol. 38","author":"Kiran","year":"2016"},{"key":"10.1016\/j.ejmech.2026.119037_bib12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2017.00772","article-title":"Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: a systematic review","volume":"8","author":"Kroesen","year":"2017","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119037_bib13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/biom10091307","article-title":"Effects of new NSAID-CAI hybrid compounds in inflammation and lung fibrosis","volume":"10","author":"Lucarini","year":"2020","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119037_bib14","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3390\/ijms20081923","article-title":"Pain relieving effect of-NSAIDs-CAIs hybrid molecules: systemic and intra-articular treatments against rheumatoid arthritis","volume":"20","author":"Micheli","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119037_bib15","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1021\/acs.jmedchem.8b00420","article-title":"Discovery of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs\u2013CAIs) for the management of rheumatoid arthritis","volume":"61","author":"Akgul","year":"2018","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119037_bib16","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/acs.jmedchem.9b01130","article-title":"Bioisosteric development of multitarget nonsteroidal anti-inflammatory drug\u2013carbonic anhydrases inhibitor hybrids for the management of rheumatoid arthritis","volume":"63","author":"Bua","year":"2019","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119037_bib17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/acs.jmedchem.6b01607","article-title":"Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs\u2013CAIs) for the treatment of rheumatoid arthritis","volume":"60","author":"Bua","year":"2017","journal-title":"J. Med. Chem."},{"issue":"sup4","key":"10.1016\/j.ejmech.2026.119037_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/14756366.2016.1217857","article-title":"Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium","volume":"31","author":"Margheri","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119037_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.01597-16","article-title":"Identification of bicarbonate as a trigger and genes involved with extracellular DNA export in mycobacterial biofilms","volume":"7","author":"Rose","year":"2016","journal-title":"mBio"},{"issue":"19","key":"10.1016\/j.ejmech.2026.119037_bib20","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1074\/jbc.M414348200","article-title":"Structure and function of carbonic anhydrases from Mycobacterium tuberculosis","volume":"280","author":"Covarrubias","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119037_bib21","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.bmcl.2009.10.009","article-title":"Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active \u03b2-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c","volume":"19","author":"Carta","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119037_bib22","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1021\/jm9003126","article-title":"Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new \u03b2-carbonic anhydrase from Mycobacterium tuberculosis","volume":"52","author":"Nishimori","year":"2009","journal-title":"J. Med. Chem."},{"issue":"140","key":"10.1016\/j.ejmech.2026.119037_bib23","article-title":"Modeling tuberculosis in Mycobacterium marinum infected adult zebrafish","author":"Luukinen","year":"2018","journal-title":"JoVE J."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119037_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002944","article-title":"Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish","volume":"8","author":"Parikka","year":"2012","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119037_bib25","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase: I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119037_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1457012","article-title":"A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis \u03b3-carbonic anhydrase inhibitors","volume":"15","author":"Manaithiya","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119037_bib27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119037_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.01439-20","article-title":"Most-probable-number-based minimum duration of killing assay for determining the spectrum of rifampicin susceptibility in clinical Mycobacterium tuberculosis isolates","volume":"65","author":"Vijay","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119037_bib29","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.1073\/pnas.2134250100","article-title":"Genetic requirements for mycobacterial survival during infection","volume":"100","author":"Sassetti","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119037_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00568-24","article-title":"Carbon dioxide regulates Mycobacterium tuberculosis PhoPR signaling and virulence","volume":"93","author":"Dechow","year":"2025","journal-title":"Infect. Immun."},{"issue":"28","key":"10.1016\/j.ejmech.2026.119037_bib31","doi-asserted-by":"crossref","first-page":"25209","DOI":"10.1021\/acsomega.3c02311","article-title":"CanB, a druggable cellular target in Mycobacterium tuberculosis","volume":"8","author":"Degiacomi","year":"2023","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119037_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00651-22","article-title":"ATP bioluminescence assay to evaluate antibiotic combinations against extensively drug-resistant (XDR) Pseudomonas aeruginosa","volume":"10","author":"Puig-Collderram","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119037_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/dkw421","article-title":"Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model","volume":"72","author":"Dalton","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119037_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1107\/S090744491200251X","article-title":"JLigand: a graphical tool for the CCP4 template-restraint library","volume":"68","author":"Lebedev","year":"2012","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119037_bib35","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.bmcl.2012.05.083","article-title":"Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines","volume":"22","author":"Winum","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119037_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejmech.2017.03.026","article-title":"Structure activity study of carbonic anhydrase IX: selective inhibition with ureido-substituted benzenesulfonamides","volume":"132","author":"Mboge","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119037_bib37","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.bmcl.2012.01.129","article-title":"New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II","volume":"22","author":"Carta","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119037_bib38","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/14756366.2017.1356295","article-title":"Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo [d] thiazole-5-and 6-sulfonamides","volume":"32","author":"Abdoli","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119037_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0024-2016","article-title":"Mycobacterial biofilms: revisiting tuberculosis Bacilli in extra-cellular necrotizing lesions","volume":"5","author":"Basaraba","year":"2017","journal-title":"Microbiol. Spectr."},{"issue":"52","key":"10.1016\/j.ejmech.2026.119037_bib40","first-page":"3094","article-title":"Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex for first and second line drugs by broth dilution in a microtiter plate format","author":"Hall","year":"2011","journal-title":"JoVE J."},{"key":"10.1016\/j.ejmech.2026.119037_bib41","first-page":"1","article-title":"Rapid evaluation of toxicity of chemical compounds using zebrafish embryos","author":"Aspatwar","year":"2019","journal-title":"JoVE J."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:12:49Z","timestamp":1785874369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S0223523426004824"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119037","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-in-class nonsteroidal anti-inflammatory drug and carbonic anhydrase inhibitor hybrid compounds as effective antimycobacterial agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119037"}}